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Association between clinical 
and environmental factors 
and the gut microbiota profiles 
in young South African children
Kristien Nel Van Zyl1*, Andrew C. Whitelaw1,2,3, Anneke C. Hesseling4, James A. Seddon4,5, 
Anne‑Marie Demers4 & Mae Newton‑Foot1,2
Differences in the microbiota in populations over age and geographical locations complicate cross‑
study comparisons, and it is therefore essential to describe the baseline or control microbiota in 
each population. This includes the determination of the influence of demographic, clinical and 
environmental factors on the microbiota in a setting, and elucidates possible bias introduced by 
these factors, prior to further investigations. Little is known about the microbiota of children in South 
Africa after infancy. We provide a detailed description of the gut microbiota profiles of children from 
urban Cape Town and describe the influences of various clinical and environmental factors in different 
age groups during the first 5 years of life. Prevotella was the most common genus identified in the 
participants, and after infancy, the gut bacteria were dominated by Firmicutes and Bacteroidetes. 
In this setting, children exposed to antibiotics and indoor cooking fires were at the most risk for 
dysbiosis, showing significant losses in gut bacterial diversity.
There is a growing appreciation of the influence of the human microbiome on health. The gut microbiome, in 
particular, has been linked to many functions that are important for good health, such as aiding the develop-
ment of a healthy immune system, protecting the gut against pathogen-adherence and producing antimicrobial 
 compounds1–3.
Disruption or dysbiosis of the gut microbial community (microbiota) has a significant impact on human 
health and has been linked to multiple metabolic, immunological, and developmental  disorders4. This is espe-
cially significant in children, where the first 1000 days of life from conception to the age of two are crucial for 
the development of various developmental pathways, including immunity and  metabolism5,6. Dysbiosis in early 
life can disrupt these pathways and possibly have long term implications for growth and  health7. For example, 
antibiotic use has been associated with increased risk of asthma, allergies, eczema, necrotizing enterocolitis 
(NEC) and inflammatory bowel disease (IBD)8. Infants delivered via caesarean section have an increased risk for 
atopic diseases such as asthma, type 1 diabetes, coeliac disease and food allergies compared to those delivered 
 vaginally8,9. Conversely, probiotic exposure and breastfeeding have been associated with decreased incidence 
of asthma, food-related allergies and  IBD8. While it is not always possible to identify the source of dysbiosis, 
associations between specific microorganisms and dysbiosis have been found in several diseases in children, 
including NEC, IBD, obesity, atopy and asthma, and autism-spectrum  disorder10.
Knowing which factors may influence the microbiota could inform dysbiosis-prevention strategies. How-
ever, microbiota profiles vary with age and health status and are heterogeneous across geographical regions. It is 
therefore important to describe the baseline microbiota in different populations and to investigate the influence 
of setting-specific clinical, environmental, socio-economic and other factors on the microbiota.
There is a marked difference between the microbiota in urban westernised populations, and those in rural 
and developing settings, in adults and  children11–14. In South Africa, the microbiota of adults represents a tran-
sitional state between the typical profiles in western populations and other African  populations15. There is little 
known about the microbiota of children in South Africa, especially after infancy. A small number of South 
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African studies have recently explored the human gut microbiota in young children, but they have either been 
birth cohorts evaluating infants under the age of 1  year16,17 or have included only children with specific diseases 
or  disorders18,19.
The aim of this study was to characterize the bacterial gut microbiota profiles of children below 5 years of age 
living in urban Cape Town communities. We investigated the influence of various clinical and environmental 
factors on the gut bacterial profiles of these children and sought to describe differences in bacterial microbiota 
in different age groups during the first 5 years of life.
Materials and methods
Study design. This study was nested in the ongoing phase III, cluster randomised, double-blinded, placebo-
controlled tuberculosis child multidrug-resistant preventive therapy (TB-CHAMP) trial (Registration date: 
31/03/2016; Registration number: ISRCTN92634082; http:// www. isrctn. com/ ISRCT N9263 4082) which aims to 
assess the efficacy and safety of levofloxacin as preventive therapy in children exposed to multidrug-resistant 
(MDR) tuberculosis (TB) within the household.
Participants were recruited from urban communities (often living in over-crowded and/or informal hous-
ing conditions) in the Cape Town metropolitan area (Western Cape, South Africa) which has a population of 
4 million people. The TB incidence rate in the Western Cape was 681/100,000 in  201520. The antenatal HIV 
prevalence was 15.9% for the province in  201721. In the same year, the South African Medical Research Council 
estimated infant mortality rate in South Africa at 23 per 1000 live births, whereas the under-five mortality rate 
was 32 per 1000  births22.
Participants were eligible if they were aged < 5 years and were a household contact of an enrolled adult index 
case (≥ 18 years of age) with bacteriologically confirmed pulmonary MDR-TB and if informed consent from 
the parent or legal guardian of the child was obtained for HIV testing and enrolment in the study. Exclusion 
criteria included presenting with TB disease at enrolment, receiving isoniazid or any fluoroquinolone treatment 
for ≥ 14 days at screening, receiving TB treatment in the previous 12 months, known exposure to an isoniazid-
susceptible TB index case and those diagnosed with Myasthenia gravis or Guillain–Barré syndrome.
Stool samples were collected from child participants at their baseline trial visit (before randomisation into the 
treatment or placebo groups), from November 2017 until July 2019, and subjected to 16S rRNA gene amplicon 
sequencing to characterise the bacterial microbiota. Approval to conduct the TB-CHAMP trial was obtained 
from the Stellenbosch University Human Research Ethics Committee (SU-HREC, M16/02/009), South African 
Health Products Regulatory Authority (20160128) and local health authorities. This sub-study was conducted at 
Stellenbosch University in Cape Town only and ethical approval was obtained from the SU-HREC (S18/02/031). 
The research from both the parent trial and this sub-study were conducted as outlined by Stellenbosch Univer-
sity’s Policy for responsible research conduct in human participants and guidelines set out by the World Health 
Organization (WHO) and the Declaration of Helsinki.
Demographic, clinical and environmental data collection. Extensive systematic data collection was 
undertaken at the baseline visit through clinical interview, questionnaire to the household, and physical exami-
nation. Participant demographics and clinical and environmental factors such as HIV status, medical history 
(including mode of birth, antibiotic use, deworming and hospitalisation), exposure to cigarette smoke, indoor 
cooking fires, breastfeeding and exposure to pets and day-care was recorded. Mid-upper arm circumference 
(MUAC) scores were used as an indicator of malnutrition in participants > 6 months. A MUAC of > 13.5 cm 
indicates a low risk for malnutrition, while a MUAC between 12.5 and 13.5 cm indicates mild risk for malnu-
trition. The following were used as indicators of socio-economic status: housing structure type, ablution type 
and drinking water supply. Where relevant, children were grouped into three age bands: A (0–1 years), B (> 1 
to 2 years) and C (> 2 to < 5 years), to account for the highly evolving nature of the gut microbiota during early 
childhood.
Sample collection. Stool samples (1 per child) were collected in sterile 25 ml faecal containers with spoons 
(Lasec, South Africa) without preservative and transported to the laboratory in cooler boxes with ice packs 
within 72 h, where they were homogenised and immediately stored at − 80 °C. Samples were stored on ice packs 
(n = 49) or in a fridge at 2–8 °C (n = 59) before transport. In a small number of cases (n = 8) no such facilities were 
available, and samples were stored at room temperature. Sample weight and consistency prior to homogenisation 
were also recorded.
DNA extraction and sequencing. DNA was extracted using the QIAamp PowerFecal DNA Isolation Kit 
(Qiagen, Germany) according to the manufacturer’s instructions. Samples that did not meet the purity require-
ments of the sequencing provider were subjected to ethanol-based purification. The extracted DNA was frozen 
at − 20 °C until delivery on ice to the Centre for Proteomic and Genomic Research (CPGR) where 16S rRNA 
gene amplicon sequencing was performed on the Illumina MiSeq platform. Previously published  primers16 were 
used to target the V4 hypervariable region. The MiSeq Reagent v3 Kit (600 cycles) was used to generate sequenc-
ing libraries, which were spiked with 10% of a 5 pM PhiX sequencing control. The ZymoBIOMICS Microbial 
Community DNA standard (Zymo Research, USA) and batched negative extraction controls were included in 
the sequencing run, which was set to produce 2 × 200 bp paired-end reads. The DNA purity requirements and 
sequencing controls are described in detail in the “Supplementary material”.
Sequence analysis and statistical testing. Sequence quality analysis. De-multiplexed paired-
end FASTQ sequences were imported to and analysed with the Quantitative Insights Into Microbial Ecology 
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(QIIME2 2020.8) bioinformatics  platform23 on the Stellenbosch University high performance computing cluster 
(HPC) 2 (http:// www. sun. ac. za/ hpc). Primer sequences were removed with  cutadapt24, followed by error correc-
tion, quality filtering and chimera removal using the dada2 plug-in25.
Taxonomic profiling. A Naïve Bayes classifier trained on the SILVA 138 99% OTU V4 region database (https:// 
www. arb- silva. de/ silva- licen se- infor mation/) was used to assign  taxonomy26,27. Taxonomic features appearing 
in less than five samples, as well as unassigned and non-bacterial features were filtered prior to visualizing the 
taxonomy bar plots.
Alpha and beta diversity testing. Rarefaction plots were generated with feature frequency and Shannon diver-
sity, and five samples were excluded from all alpha and beta diversity analyses after rarefying to a sequencing 
depth of 52,653. Univariate analysis was performed for individual factors, samples with no data were automati-
cally excluded and the p value for significance was set at 0.05 for all calculations. The evenness and richness 
(alpha diversity) within groups (based on the factors defined under the demographic, clinical and environmental 
data section) was calculated using the Shannon (H) and Faith’s Phylogenetic Diversity (PD) diversity  metrics28,29 
and statistical significance between groups was determined using Kruskal–Wallis pairwise tests and Benjamini–
Hochberg False Discovery Rate (BH-FDR) multiple test correction where  appropriate30,31. Spearman correlation 
analysis was performed for numerical  data32. The differences in microbial communities between groups were 
investigated by principal coordinate analysis (PCoA) using the Bray–Curtis, and unweighted and weighted Uni-
Frac dissimilarity  metrics33,34. Significance of differences were determined by  PERMANOVA35 with BH-FDR 
adjustment where appropriate.
Differential abundance analysis. Analysis of composition of microbiomes (ANCOM)36 was used to identify 
differentially abundant features at genus level for factors such as age, medication use, method of birth, breast-
feeding and exposure to pets and smoke. The selection of factors to investigate for possible bacterial biomarkers 
was guided by clustering in the PCoA space following beta diversity analysis. For all ANCOM analyses, recom-
mended filtering was performed to include only features present ≥ 20 times overall and in at least 25% of the 
samples, to remove noise caused by less abundant features.
Results
Participant demographics. Stool samples were collected from 116 of 218 children enrolled in Cape Town 
over the study period. Of these, after DNA extraction, only a single sample failed to meet the DNA purity 
requirements; the sample and corresponding participant data were excluded from analysis. The participant 
demographics and exposures to different clinical and environmental factors have been summarised in Tables 1 
Table 1.  Participant demographics and health status.
Demographics





Normal vaginal delivery 80 (69.6%)
Caesarean section 32 (27.8%)
Unknown 3 (2.6%)












MUAC (children > 6 months)
 > 13.5 cm 104 (96.3%)
 ≤ 13.5 cm 4 (3.7%)
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and 2 respectively, and additional details regarding breastfeeding habits and day-care exposure can be found 
in Supplementary Table S1. The median age of the children was 32 months (interquartile range [IQR]: 15–43). 
There were 60 (52.2%) boys, and only one confirmed HIV-positive child. Only four children over the age of 
6 months had a MUAC of < 13.5 cm. 
Sequencing and taxonomy profiles. A total of 9,481,364 paired reads were imported into QIIME2 and 
no trimming was performed due to high quality across all bases in both forward and reverse reads (median 
≥ Q30). After quality filtering and chimera removal, a total of 8,019,511 paired reads remained (7,766,477 
excluding controls, median: 67,517 reads/sample, IQR: 61,452–72,667). Taxonomic profiles were generated for 
each sample at phylum level and ordered by age group (Fig. 1). At phylum level, children younger than 1 year 
had a higher relative abundance of Proteobacteria (16.6%) and Actinobacteriota (9.8%) compared to those older 
than 2 years (Proteobacteria: 4.6%, Actinobacteriota: 2.9%). In children between the age of 2−5 years, the profiles 
were dominated by Firmicutes (45.1%) and Bacteroidota (44.9%). At genus level, there was a notable abundance 
of Bifidobacterium, Escherichia-Shigella and Veillonella in infants, whereas the most prevalent genus overall was 
Prevotella (Fig. 2).
Alpha diversity. The influence of various factors on the richness and evenness of bacteria in samples was 
determined by calculating Shannon’s H and Faith’s PD indexes (Fig. 3, Supplementary Tables S2 and S3). An 
increase in richness and evenness was observed during the first 3 years of life, as shown by Shannon’s H index 
(Fig. 3A) and Faith’s PD (Supplementary Table S2). The upper three 1-year age bands did not differ significantly 
from each other, indicating a stabilization of within-sample diversity. There were no significant differences in 
alpha diversity due to sex (M/F) or due to the mother’s HIV status. The method of sample storage, sample con-
sistency and sample weight did not impact alpha diversity.
For factors more directly linked to age, such as method of birth (caesarean (C/S) vs normal vaginal delivery 
(NVD)), feeding pattern and day-care exposure, the data were stratified into three age groups: group A (0–1; 
n = 24), group B (> 1 to 2; n = 25) and group C (> 2 to 5; n = 66). None of these age-related factors were associ-
ated with changes in alpha diversity in any of the age groups, including method of birth (C/S vs NVD), pre-
mature birth, breastfeeding in the first 6 months (including exclusive breastfeeding), duration of breastfeeding 
(in months) and age of solid food introduction. In addition, none of the factors relating to day-care exposure, 
including the age at which day-care was started, size of day-care groups or hours spent in day-care, were associ-
ated with differences in alpha diversity in the oldest age group (Supplementary Tables S2 and S3).
Alpha diversity was significantly lower in those who had received antibiotics in the 2 weeks prior to sample 
collection (H: Fig. 3B, p = 0.005), but no difference was seen between children who had or had not received 
antibiotics in the last 6 months. Children who had received treatment from a traditional healer in the last 3 years 
had lower diversity (Fig. 3B; p = 0.01), while those who had been dewormed in the 6 months prior to sample 
collection had significantly higher diversity (Fig. 3B; p = 0.029). Vitamin A supplementation in those older than 
6 months, hospitalisation in the 6 months prior to sample collection and hospitalisation in the first 6 months of 
life did not affect alpha diversity.
While there were no significant differences between children exposed to cigarette smoke during pregnancy 
or in the household, those exposed to an indoor cooking fire using wood or paraffin (kerosene) had significantly 
lower diversity (Fig. 3C; p = 0.004). Children who lived in a home with pets (cats or dogs) had significantly 
higher diversity (Fig. 3C; p = 0.03). The type of housing structure, ablutions and drinking water supply did not 
affect alpha diversity.
Beta diversity. Like richness and evenness, differences in age were also associated with dissimilarity in the 
gut microbial community. The PCoA plots generated by the Bray–Curtis (BC), unweighted UniFrac (UWU) and 
weighted UniFrac (WU) dissimilarity metrics showed distinct clustering of samples in age groups A (0–1 years) 
and C (> 2 to 5 years), and a transitional cluster representing age group B (> 1 to 2 years) (Fig. 4). PERMANOVA 
testing showed that groups A and B were dissimilar to group C and each of its subgroups (> 2 to 3 years, > 3 to 
4 years, and > 4 to 5 years), and that the subgroups of group C did not differ from each other.
There were significant differences in the bacterial communities when considering receipt of antibiotics in 
the 2 weeks prior to sample collection (BC: p = 0.001; UWU: p = 0.001; WU: p = 0.001), those who had visited 
a traditional healer in the last 3 years (BC: p = 0.009; UWU: p = 0.002; WU: p = 0.003), and deworming within 
6 months (BC: p = 0.01; UWU: p = 0.011; WU: p = 0.039). Vitamin A supplementation trended toward, but did 
not significantly influence community dissimilarity (BC: p = 0.075; UWU: p = 0.067; WU: p = 0.286). Exposure 
to indoor cooking fires (BC: p = 0.036; UWU: p = 0.012; WU: p = 0.177), rather than cigarette smoke exposure 
(BC: p = 0.174; UWU: p = 0.366; WU: p = 0.133) was associated with a community shift, when considering most 
dissimilarity metrics. No other clinical, environmental or socio-economic factors influenced the gut microbial 
communities significantly. When stratified by age, no significant associations with any age-linked factors were 
identified.
Differential abundance with ANCOM. Differential abundance analysis was performed to identify pos-
sible bacterial biomarkers associated with the differences between groups following alpha- and beta-diversity 
analysis. These analyses support the observed age-related differences in alpha and beta diversity, and the transi-
tional nature of the microbiome during infancy. Sixteen differentially abundant genera were identified between 
groups A and C, 7 between groups A and B, and 5 between groups B and C (Fig. 5). When comparing the age 
groups A and C, only three features (an uncultured genus-level group (UCG) from the Oscillospiraceae (UCG-
002), Agathobacter and a genus group in the Lachnospiraceae family) were more abundant in the older age 
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Clinical factors
Received antibiotics (< 2 weeks from baseline)
Beta-lactam (amoxicillin) 12 (10.4%)
Fluoroquinolone alone 3 (2.6%)
Fluoroquinolone + Cotrimoxazole + Ethambutol 1 (0.9%)




Hospital admission (< 6 months from baseline)
Yes 7 (6.1%)
No 108 (93.9%)




Visit to traditional healer (< 3 years from baseline)
Yes 9 (7.8%)
No 106 (92.2%)
Dewormed* (< 6 months from baseline)
Yes 26 (44.1%)
No 33 (55.9%)



















Tin shack 30 (26.1%)
Brick structure 75 (65.2%)
Wendy house 6 (5.2%)
Backyard shack of another house 1 (0.9%)
Prefabricated house 3 (2.6%)
Ablution type
Bucket system 8 (7%)
Flush toilet in the house 66 (57.4%)
Shared flush toilet 18 (15.6%)
Flush toilet outside the house but for exclusive use 15 (13%)
Pit latrine 4 (3.5%)
Ventilated improved pit (VIP) latrine 4 (3.5%)
Drinking water supply
Piped water from a public shared tap 23 (20%)
Piped water in the residence 84 (73%)
Piped water outside, but for exclusive use of the household 8 (7%)
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group. A number of features from the Actinobacteriota and Proteobacteria were significantly more abundant 
in the youngest age group. There was a significant increase in genera from the order Clostridia in group B, as 
compared to group A. The differentially abundant genera between groups B and C belong to the same phylum 
and therefore do not represent major global changes in the microbiota.
Prevotella was enriched in those not exposed to antibiotics in the 2 weeks prior to sample collection and 
Haemophilus was more abundant in those who had been dewormed. The differences in microbiota composition 
due to antibiotic treatment and deworming are shown in Supplementary Fig. S1. Other clinical and environ-
mental factors that were associated with changes in diversity did not have any significant bacterial biomarkers. 
Factors that have been known to influence the microbiome in the first year of life, such as method of birth, 
prematurity and breastfeeding, were not associated with any differentially abundant features in group A or the 
older age groups.
Discussion
This study characterized the bacterial gut microbiota profiles of children from urban communities in Cape Town, 
South Africa. Diversity and differential abundance analyses were performed in the context of various demo-
graphic, clinical and environmental factors. It was found that the richness and evenness of the bacterial micro-
biota in this population stabilize after infancy and that age is the main driver of differences between participants.
The gut microbiota of children in this study shows similar maturation patterns to those described previously 
in both urban and rural settings, where a shift occurs from Proteobacteria and Actinobacteria such as Escheri-
chia and Bifidobacterium in early life, to Firmicutes/Bacteroidota dominated profiles represented by Prevotella 
and Bacteroides after  infancy11,37,38. Prevotella was the most common genus in older children (> 2 years) in our 
study; this is comparable to studies done in other developing  countries11,39,40. A recent South African study that 
evaluated the association between diet and atopic dermatitis in children found that the higher abundance of 
Prevotella in healthy controls may indicate a protective effect against atopic  dermatitis18. There was no depletion 
of Bacteroides, as has been noted in some child and adult studies in rural African  communities41,42. At phylum 
level, the microbiota profiles in this study were more similar to those of children in studies from the United 
States of America (USA) than those from Asia, Europe and Africa, with an equal distribution of Firmicutes and 
 Bacteroidota11,39,40. This intermediate state between the microbial profiles of traditionally non-western microbi-
omes and western microbiomes has also been described in South African adults and has been attributed in part 
to urbanization and changes in  diet15. A limitation of our study was that the dietary intake of the children was 
not recorded, and the impact of different diets on the gut microbiota could therefore not be investigated in this 
population. We found no significant differences in diversity or bacterial features when considering age-related 
factors known to influence the gut microbiota in early life, such as method of birth, prematurity, breastfeeding 
and day-care exposure. This may be related to the smaller number of participants when stratifying by age group, 
which limited the statistical analysis.
A significant increase in potential short-chain fatty acid (SCFA) producing taxa was noted after the first year 
of life, including members of the Lachnospiraceae, Oscillospiraceae and Ruminococcacaea families. Agathobacter, 
Butyricicoccus and Lachnospiraceae NK4A136 group were among the taxa which increased in abundance with 
age; these taxa have previously been identified as potential probiotic  targets43–45. Faecalibacterium, another taxon 
associated with good health in  adults46, represented a substantial proportion of the gut bacteria in this study.
Reduced microbial diversity was associated with antibiotic treatment within 2 weeks of sample collection, vis-
iting traditional healers within 3 years and living in a home with an indoor wood or paraffin cooking fire, which 
may have placed children at risk for dysbiosis. It should be noted that all but one child in the small group who 
had visited traditional healers were below the age of two, and lower diversity in this univariate evaluation is thus 
likely to be driven by age. Of note, all of these children had visited the healers due to minor issues such as colic. 
In this study, only Prevotella was found to be significantly reduced in those who had recently taken antibiotics. No 
significant differences in microbial profiles or diversity were observed in children exposed to antibiotics within 
6 months of sample collection, suggesting resilience and recovery of the microbiome after short-term antibiotic 
use. However, these children are exposed to MDR-TB in the household, may be biased toward living in poorer 
socio-economic conditions and they are likely to have a higher rate of antibiotic consumption and hospitalisa-
tion in the longer term, which may impact the microbiome. The possible selection of resistant organisms has 
not been considered here, but there is contradictory evidence regarding the long-term effect of antibiotic use on 
the levels of resistance in the  gut47–49, highlighting the need for more long-term resistome surveillance studies. 
For populations such as the one included in this study, this is particularly important.
Consistent with a pilot study in our  setting50, the different storage methods used in this study did not signifi-
cantly influence the microbiota. We also did not find any associations between diversity and sample consistency 
and weight. Further studies with larger sample sizes need to be conducted to explore the potential benefits of 
unrefrigerated sample transport for studies set in remote or resource-limited settings.
Table 2.  Participant exposure to clinical and environmental factors. Data expressed as number (%). 
*Deworming was recorded on more than one case report form; data presented includes only participants for 
whom answers matched on both forms (n = 59).
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Exposure to indoor cooking fires rather than cigarette smoke was associated with a reduction in alpha diver-
sity and significant bacterial community dissimilarity between samples, although no differentially abundant 
features could be identified. Wood and kerosene fires produce high levels of household pollutants, including a 
mixture of gases and particulate matter (PM). The WHO attributes 3.8 million deaths a year to household air 
 pollution51, yet the relationship between PM and the microbiome is not well studied. Liu and colleagues recently 
reported that exposure to certain PM was associated with a reduction in alpha  diversity52; however, results in 
animal studies have been  conflicting53,54. Further studies are needed to improve our understanding of the impact 
of the use solid fuel and kerosene on gut microbiome related health in low- and middle-income countries.
In this study, deworming within 6 months of sample collection was associated with increased overall diversity 
and an increase in the abundance of Haemophilus. A Kenyan study determined that albendazole-based deworm-
ing resulted in an increase in Clostridiales and reduction of Enterobacterales; however the overall diversity 
decreased post-treatment55. In comparison, a study that investigated various anthelminthic agents did not observe 
Figure 1.  Taxonomic profiles of participant samples at phylum level. The brackets on the x-axis show the 
different age bands by year and samples within each band are ordered by increasing age. Features appearing in 
less than five samples, as well as unassigned and non-bacterial features were removed to simplify visualization.
Figure 2.  The relative abundance of the top ten genera in each of the five age groups.
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Figure 3.  Shannon’s H alpha diversity plotted for significant factors (p < 0.05). (a) Age bands separated by year 
of life. Lines indicate significant differences between the groups at each end of the line. There were no significant 
differences between the groups representing the oldest three age bands. (b) Clinical factors, including receipt of 
antibiotics within 2 weeks from sample collection, treatment from traditional healer within 3 years from sample 
collection, and deworming within 6 months from sample collection. (c) Environmental factors, including 
exposure to an indoor cooking fire using paraffin or wood, and exposure to pets in the household (cats/dogs). 
Faith’s PD results have been summarised in Supplementary Table S2.
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any significant changes in alpha diversity but did find an association between combination tribendimidine and 
ivermectin therapy, and an increase in the phylum  Bacteroidetes56. Similarly, alpha diversity was not affected 
by deworming therapy in hospitalised South African infants, but the bacterial gut microbiota communities of 
dewormed infants were found to be dissimilar to those who had not been  dewormed19. Interestingly, a decrease 
in the relative abundance of Bacteroidetes has been associated with individuals who remained infected with 
helminths following deworming  therapy57. As noted in this study, Yang et al. found that deworming resulted in 
a short-term increase in bacterial diversity, and additionally noted an increase in the probiotic Bifidobacterium, 
and decrease in Fusobacteria; however, this was dependent on the pre-treatment microbial  profile58. They also 
suggested a possible link to increased secretory IgA (SIgA) following  treatment58. In a recent study, people with 
SIgA deficiency were shown to have significantly less diverse microbiomes when compared to healthy  controls59. 
SIgA is also known to aid in pathogen control and limit inflammation in the gut, thereby contributing to gut 
 homeostasis60. However, the relationship between SIgA and deworming has not been established and needs 
further evaluation. There are no reports in the literature linking Haemophilus abundance to deworming. A study 
performed on South African infants determined that Haemophilus was a candidate gut pathogen associated with 
respiratory disease in  infants19, but the clinical significance of Haemophilus outside of specific disease contexts is 
unknown. Further, we were only able to include 59 of 115 children in this analysis due to discrepant answers on 
the questionnaires, and did not evaluate the helminth infection status, which has been associated with specific 
microbiome  profiles61. The numerous benefits of deworming in child health, such as control of anaemia and a 
lower risk of stunting and malnutrition, must also be considered and may mediate perceived negative micro-
biome effects. Like deworming, living with pets was also linked to an increase in gut microbial diversity. This 
relationship has previously been shown in infants, and changes in the abundance of a number of taxa have been 
associated with exposure to  pets62,63; however, this was not seen in this study.
This cohort presented the rare opportunity to describe the microbiota of relatively healthy children from 
South African communities. The differences in the microbiota during the first 5 years of life in this setting are 
similar to what has been described elsewhere, and the abundance of taxa previously associated with good health 
indicates a low level of dysbiosis in this population. Those exposed to antibiotics and indoor wood/kerosene 
cooking fires were at the greatest risk for dysbiosis with significant losses in community diversity. This highlights 
the importance of continued and increased microbial surveillance in populations exposed to antibiotics and 
indoor cooking fires. Considering that it can be difficult to draw comparisons between 16S rRNA gene sequenc-
ing studies, due to the variance introduced by DNA extraction, sequencing and taxonomic profiling strategies, 
further functional studies are necessary to elucidate the full impact of environmental factors on the metabolic 
and immunological pathways connected to the microbiome. The extensive baseline metadata analysis performed 
here provides the ideal platform for future studies in this setting that will aim to identify the long-term impact 
of fluoroquinolones on the child gut microbiome and resistome; after the parent trial has been completed and 
the researchers can be unblinded.
Figure 4.  Two-dimensional PCoA plots based on three dissimilarity metrics. The three age groups are shown 
by colour. Yellow = A (0–1); Red = B (> 1 to 2); Blue = C (> 2 to 5). Group C is further subcategorized by shape. 
(a) Bray–Curtis, (b) Unweighted UniFrac, (c) Weighted UniFrac.
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Figure 5.  ANCOM generated volcano plots showing differentially abundant features between the age groups. 
W is the ANCOM test statistic and indicates the number of times the null hypothesis is rejected by the analysis. 
The higher W, the more likely a feature differs statistically. clr indicates the effect size change between the 
compared groups. Statistically significant features as identified by ANCOM have been labelled. (a) Comparison 
between groups A & C. A positive clr indicates higher abundance in A compared to C. (b) Comparison between 
groups A & B. A positive clr indicates higher abundance in B compared to A. (c) Comparison between groups B 
& C. A positive clr indicates higher abundance in C compared to B.
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Data availability
The sequencing data has been made available through the NCBI Sequence Read Archive under BioProject 
PRJNA692358.
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